CTMX vs REGN: Which Stock is Better?

Side-by-side comparison of CytomX Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CTMX

CytomX Therapeutics Inc

$5.37

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricCTMXREGNWinner
Market Cap$913.26M$77.77BREGN
P/E Ratio17.9717.58REGN
EPS (TTM)$0.30$41.75REGN
Revenue Growth-0.8%0.0%REGN
Gross Margin100.0%45.8%CTMX

Analyze CTMX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CTMX or REGN a better investment?

Comparing CTMX and REGN: CytomX Therapeutics Inc has a market cap of $913.26M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CTMX and REGN?

CTMX (CytomX Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CTMX or REGN?

Based on P/E ratios, REGN trades at a lower multiple (17.6x vs 18.0x).

Which is growing faster: CTMX or REGN?

REGN has higher revenue growth at 0.0% vs -0.8% for CTMX.

Which company is more profitable: CTMX or REGN?

CytomX Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 45.8% for REGN.

Which is the larger company: CTMX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $913.26M for CTMX.

Should I buy CTMX or REGN in 2026?

Both CTMX and REGN have investment merit. CTMX trades at $5.37 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CTMX and REGN stock?

Key differences: Market Cap ($913.26M vs $77.77B), P/E Ratio (18.0x vs 17.6x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 45.8%).

Popular Stock Comparisons